These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19662830)

  • 21. Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran.
    Ghafari S; Sharifzadeh G; Jamali S; Taji B; Javadmoosavi SY; Ziaee M
    Arch Iran Med; 2019 Sep; 22(9):501-504. PubMed ID: 31679371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
    Tun W; Vu L; Adebajo SB; Abiodun L; Sheehy M; Karlyn A; Njab J; Ahonsi B; Issa BK; Idogho O
    Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ
    Vaccine; 2006 Mar; 24(13):2377-86. PubMed ID: 16384627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005.
    Sunthornchart S; Linkins RW; Natephisarnwanish V; Levine WC; Maneesinthu K; Lolekha R; Tappero JW; Trirat N; Muktier S; Chancharastong P; Fox K; Donchalermpak S; Vitek C; Supawitkul S
    Addiction; 2008 Oct; 103(10):1687-95. PubMed ID: 18705685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus infection risk factors and immunity among sexually transmitted disease clinic clients.
    Trepka MJ; Weisbord JS; Zhang G; Brewer T
    Sex Transm Dis; 2003 Dec; 30(12):914-8. PubMed ID: 14646641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to hepatitis B virus vaccination at syringe exchange sites.
    Altice FL; Bruce RD; Walton MR; Buitrago MI
    J Urban Health; 2005 Mar; 82(1):151-61. PubMed ID: 15746385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV epidemic in Estonia in the third decade of the AIDS era.
    Rüütel K; Uusküla A
    Scand J Infect Dis; 2006; 38(3):181-6. PubMed ID: 16507499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk prison and hepatitis B virus infection among inmates with history of drug injection in Isfahan, Iran.
    Dana D; Zary N; Peyman A; Behrooz A
    ScientificWorldJournal; 2013; 2013():735761. PubMed ID: 23737725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B vaccination of men who have sex with men in the Netherlands: should we vaccinate more men, younger men or high-risk men?
    Xiridou M; van Houdt R; Hahné S; Coutinho R; van Steenbergen J; Kretzschmar M
    Sex Transm Infect; 2013 Dec; 89(8):666-71. PubMed ID: 23812794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of a hepatitis B vaccination program for clients of a drug consumption facility.
    Scherbaum N; Timm J; Richter F; Bonnet U; Bombeck J; Lajos S; Specka M
    J Clin Virol; 2018 Sep; 106():28-32. PubMed ID: 30015286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers and facilitators to hepatitis B vaccination among sex workers in Vancouver, Canada: Implications for integrated HIV, STI, and viral hepatitis services.
    Ranjan A; Shannon K; Chettiar J; Braschel M; Ti L; Goldenberg S
    Int J Infect Dis; 2019 Oct; 87():170-176. PubMed ID: 31404673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modelling the hepatitis B vaccination programme in prisons.
    Sutton AJ; Gay NJ; Edmunds WJ; Andrews NJ; Hope VD; Gilbert RL; Piper M; Gill ON
    Epidemiol Infect; 2006 Apr; 134(2):231-42. PubMed ID: 16490125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.
    Shapatava E; Nelson KE; Tsertsvadze T; del Rio C
    Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S35-8. PubMed ID: 16769443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A window of opportunity: declining rates of hepatitis B virus infection among injection drug users in Rio de Janeiro, and prospects for targeted hepatitis B vaccination.
    Oliveira SA; Hacker MA; Oliveira ML; Yoshida CF; Telles PR; Bastos FI
    Rev Panam Salud Publica; 2005; 18(4-5):271-7. PubMed ID: 16354424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-HIV seropositivity was related to HBsAg seropositivity among injecting drug users in Taiwan.
    Hsieh MH; Hsieh MY; Huang CF; Yeh ML; Wang SC; Yang JF; Chang K; Lin WR; Lin CY; Chen TC; Huang JF; Dai CY; Tsai JJ; Chuang WL; Yu ML
    Kaohsiung J Med Sci; 2016 Feb; 32(2):96-102. PubMed ID: 26944329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program.
    Lin HH; Lee SS; Yu ML; Chang TT; Su CW; Hu BS; Chen YS; Huang CK; Lai CH; Lin JN; Wu JC
    Hepatology; 2015 Jun; 61(6):1870-9. PubMed ID: 25677884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.